Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Stylesson Jun 09, 2014 12:38pm

211 Views

Post# 22642386

RE:RE:RE:You Are out to lunch

the 2/3rd of the cash is negated by the fact they have sinced issued shares. That's a wash.

Cormark is over-valuing this thing. There's a reason they are the only broker out with a report. What's there to report on other than this is a shell with cash led by a strong management team? Nothing!

Bullboard Posts

Understanding different debt management strategies (good debt vs. bad debt)